logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us

中/EN

logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us
  • 4-2
    Praprofen eye drops have been officially approved
  • 5-1
    Join hands with Xipu · Development increment Wanhan Pharmaceutical invites you to visit and negotiate
  • 普拉洛芬喜报
    WANHAN PHARMACEUTICAL COMPANY: Praloflaxin API has been approved.
  • 溴芬酸钠单剂量获批
    WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
  • 溴芬酸钠获批
    WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium Eye Drops has been authorized.
  • 玻璃单剂量获批
    WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been successfully approved.
  • 0.3%玻璃获批
    WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops - 0.3% (5ml: 15mg) has been formally approved.
  • 莫西获批
    WANHAN PHARMACEUTICAL COMPANY: Moxifloxacin Hydrochloride Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
  • 1
  • 2
  • 3
  • 4
  • 5

Contact Us

Foreign Trade Email:

Foreign-Trade@whpt.com.cn              

Foreign-Trade1@whpt.com.cn 

 

Foreign Trade:

+86 139-2498-2439 (WhatsApp,WeChat)
+86 189-8859-3463

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.